{"id":"W2945221383","doi":"10.1038/s41416-019-0474-x","title":"A phase 2 trial of sunitinib in patients with progressive paraganglioma or pheochromocytoma: the SNIPP trial","year":2019,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Adrenal and Paraganglionic Tumors","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":true,"ca_institutions":"Foothills Medical Centre; Princess Margaret Cancer Centre; Centre Hospitalier de l’Université de Montréal; University Health Network","funders":"Pfizer Canada; Pfizer","keywords":"Paraganglioma; Sunitinib; SDHB; Medicine; Clinical endpoint; SDHA; Pheochromocytoma; Progressive disease; Internal medicine; Surgery; Metanephrines; Phases of clinical research; Oncology; Germline mutation; Randomized controlled trial; Chemotherapy; Cancer; Mutation","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001419815,0.001039632,0.001134364,0.0002606435,0.0002838019,0.0005707924,0.0004787066,0.0009003763,0.004079269],"category_scores_gemma":[0.0007460244,0.0002362453,0.0009906971,0.0001910325,0.0003532927,0.0005869312,0.0002833172,0.001797984,0.0004941594],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006107012,"about_ca_system_score_gemma":0.0009029696,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004910427,"about_ca_topic_score_gemma":0.00202281,"domain_scores_codex":[0.9996856,0.0001723037,0.00001472105,0.0000479906,0.00003231368,0.00004703594],"domain_scores_gemma":[0.9996182,0.00008735993,0.00009542115,0.00002157757,0.00002815548,0.0001492626],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.762888,0.01450767,0.01173707,0.002884864,0.003220683,0.0006264817,0.0003161903,0.006126116,0.01798065,0.0006350718,0.01177293,0.1673043],"study_design_scores_gemma":[0.7892978,0.1771734,0.0193337,0.0001326981,0.0009544981,0.0008573148,0.00008064448,0.002901841,0.002852921,0.0005613043,0.005812861,0.00004101826],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9880506,0.004680329,0.0004469565,0.0008115983,0.0001888187,0.00146082,0.001202201,0.0001086135,0.003050116],"genre_scores_gemma":[0.9901388,0.002114045,0.0008764979,0.0007315164,0.0001815374,0.001473875,0.002042098,0.00001692947,0.002424723],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004079269,"threshold_uncertainty_score":0.01364654,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01418888539045209,"score_gpt":0.3169192574547395,"score_spread":0.3027303720642874,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}